1 study on Gper agonist mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research positions `GPER` agonism as a viable and distinct therapeutic strategy for **obesity** and **type 2 diabetes**, particularly in contexts like postmenopause where traditional hormone replacement has risks…